PER 3.57% 8.7¢ percheron therapeutics limited

Parent advocacy seems to have swayed the decision. IMO...

  1. 720 Posts.
    lightbulb Created with Sketch. 210
    Parent advocacy seems to have swayed the decision.

    IMO reinforces a point I made earlier. Desperation and motivation of parents to possibly cure or stem DMD of their 4 year old, near normal, child may be different than for the non-ambulant DMD child at 14 yrs.

    Using an oncology analogy, Sarepta is offering a possible cure or extension of life at stage 4 cancer diagnosis, when the patient is asymptomatic, whereas ANP is not offering a cure, but offering an extension of life only after the disease is terminal and in the bedridden phase.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.7¢
Change
0.003(3.57%)
Mkt cap ! $78.43M
Open High Low Value Volume
8.4¢ 8.7¢ 8.4¢ $72.99K 855.8K

Buyers (Bids)

No. Vol. Price($)
2 452608 8.4¢
 

Sellers (Offers)

Price($) Vol. No.
8.7¢ 398595 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.